Natural Product: NPC281581

Natural Product IDNPC281581
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
ZKIAZXMDELJIMQ-IZLXSDGUSA-N
IUPAC Name n.a.
Synonyms (+)-2-Norcepharanthine
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL505900
PubChem CID 181384
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey ZKIAZXMDELJIMQ-IZLXSDGUSA-N
Standard InCHI InChI=1S/C36H36N2O6/c1-38-13-11-24-18-33-35(42-20-41-33)36-34(24)28(38)15-21-4-7-25(8-5-21)43-31-16-22(6-9-29(31)39-2)14-27-26-19-32(44-36)30(40-3)17-23(26)10-12-37-27/h4-9,16-19,27-28,37H,10-15,20H2,1-3H3/t27-,28+/m1/s1
SMILES COc1cc2CCN[C@H]3c2cc1Oc1c2c(CCN([C@H]2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   592.26 Volume:   605.858
?
Van der Waals volume.
Dense:   0.978 LogP:   3.268
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.071
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.03
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   46.0
TPSA:   70.65
?
Topological Polar Surface Area.
H-Bond Acceptor:   8.0
H-Bond Donor:   1.0 Rings:   9.0
Heavy Atoms:   8.0

MedChem Properties

QED Drug-Likeness Score:   0.282 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   5.845 Fsp3:   0.333
MCE-18:   138.375
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.999 Fluc inhibitor:   0.346
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.793
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.856
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.001 Promiscuous compounds:   0.32

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.937 MDCK Permeability:   -4.712
Pgp-inhibitor:   0.255 Pgp-substrate:   0.778
PAMPA:   0.038
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.126 30% Bioavailability (F30%):   0.015
50% Bioavailability (F50%):   0.955

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.748 MRP1:   0.919
Plasma Protein Binding (PPB):   83.93% Volume Distribution (VD):   0.544
Fu: 16.83%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.736
OATP1B3 inhibitor:   0.905 BCRP inhibitor:   0.247
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   1.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.993 CYP2C9-substrate:   0.811
CYP2D6-inhibitor:   1.0 CYP2D6-substrate:   0.005
CYP3A4-inhibitor:   0.997 CYP3A4-substrate:   0.051
CYP2B6-substrate:   0.987 CYP2C8-inhibitor:   0.0
HLM stability:   0.01
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.12 Half-life (T1/2):  1.897

ADMET: Toxicity

hERG Blockers:  0.859 hERG Blockers (10um):  0.81
Human Hepatotoxicity (H-HT):  0.716 Drug-induced Liver Injury (DILI):  0.124
AMES Toxicity:  0.82 Rat Oral Acute Toxicity:  0.844
Maximum Recommended Daily Dose:  0.98 Skin Sensitization:  0.734
Carcinogencity:  0.599 Eye Corrosion:  0.0
Eye Irritation:  0.017 Respiratory Toxicity:  0.911
Drug-induced Neurotoxicity:  0.926 Ototoxicity:  0.509
Hematotoxicity:  0.106 Drug-induced Nephrotoxicity:  0.617
Genotoxicity:  0.659 RPMI-8226 Immunitoxicity:  0.087
A549 Cytotoxicity:  0.236 Hek293 Cytotoxicity:  0.488
BCF:   2.042
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.536
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.2
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.548
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25189 Stephania epigaea Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[23621840]
NPO26964 Stephania erecta Species Menispermaceae Eukaryota n.a. n.a. n.a. PMID[8450319]
NPO26964 Stephania erecta Species Menispermaceae Eukaryota tubers n.a. n.a. PMID[8450319]
NPO26964 Stephania erecta Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO26964 Stephania erecta Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26964 Stephania erecta Species Menispermaceae Eukaryota tubers n.a. n.a. Database[PMID; Title]
NPO26964 Stephania erecta Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO25189 Stephania epigaea Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO26964 Stephania erecta Species Menispermaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT453 Cell line HT-1080 Homo sapiens ED50 = 1.9 ug ml-1 PMID[19921834]
NPT147 Cell line SK-MEL-2 Homo sapiens ED50 = 10.5 ug ml-1 PMID[17060530]
NPT91 Cell line KB Homo sapiens ED50 = 3.9 ug ml-1 PMID[11975502]
NPT168 Cell line P388 Mus musculus ED50 = 0.1 ug ml-1 PMID[16643039]
NPT762 Cell line A-431 Homo sapiens ED50 = 1.8 ug ml-1 PMID[17190448]
NPT858 Cell line LNCaP Homo sapiens ED50 = 3.0 ug ml-1 DrugMatrix in vivo data: Pathology
NPT133 Cell line ZR-75-1 Homo sapiens ED50 = 1.2 ug ml-1 PMID[15568800]
NPT91 Cell line KB Homo sapiens ED50 = 6600.0 nM PMID[22932311]
NPT660 Cell line SW480 Homo sapiens IC50 = 3700.0 nM PMID[9917283]
NPT659 Cell line SMMC-7721 Homo sapiens IC50 = 4800.0 nM PMID[9917283]
NPT83 Cell line MCF7 Homo sapiens IC50 = 2300.0 nM DrugMatrix in vivo data: Pathology
NPT116 Cell line HL-60 Homo sapiens IC50 = 2800.0 nM DrugMatrix in vivo data: Pathology
NPT81 Cell line A549 Homo sapiens IC50 = 3700.0 nM PMID[10924160]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum ED50 = 46.6 ng/ml PMID[18494522]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum ED50 = 129.4 ng/ml PMID[19397322]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 79.0 nM PMID[17253846]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 219.0 nM PMID[10775404]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 3200.0 nM PMID[23621840]
NPT2 Others Unspecified n.a. Ratio ED50 = 36.0 n.a. PMID[17988099]
NPT2 Others Unspecified n.a. Ratio ED50 = 13.0 n.a. PMID[26241103]
NPT2 Others Unspecified n.a. Ratio ED50 = 41.0 n.a. PMID[27077705]
NPT2 Others Unspecified n.a. Ratio ED50 = 15.0 n.a. PMID[12662094]
NPT2 Others Unspecified n.a. Ratio ED50 = 43.0 n.a. PMID[17844993]
NPT2 Others Unspecified n.a. Ratio ED50 = 16.0 n.a. DrugMatrix in vivo data: Pathology
NPT2 Others Unspecified n.a. Ratio ED50 = 225.0 n.a. PMID[15026054]
NPT2 Others Unspecified n.a. Ratio ED50 = 81.0 n.a. PMID[17477572]
NPT2 Others Unspecified n.a. Ratio ED50 = 67.0 n.a. PMID[19651905]
NPT2 Others Unspecified n.a. Ratio ED50 = 24.0 n.a. PMID[20303767]
NPT2 Others Unspecified n.a. Ratio ED50 = 84.0 n.a. PMID[19926364]
NPT2 Others Unspecified n.a. Ratio ED50 = 30.0 n.a. PMID[23571415]
NPT2 Others Unspecified n.a. Ratio ED50 = 11.0 n.a. PMID[23398362]
NPT2 Others Unspecified n.a. Ratio ED50 = 2.0 n.a. PubChem BioAssay data set
NPT2 Others Unspecified n.a. Ratio ED50 = 1.0 n.a. PMID[7473549]
NPT2 Others Unspecified n.a. Ratio ED50 = 39.0 n.a. PMID[22304344]
NPT2 Others Unspecified n.a. Ratio ED50 = 14.0 n.a. PMID[23977995]
NPT2 Others Unspecified n.a. Ratio ED50 = 64.0 n.a. PMID[15387655]
NPT2 Others Unspecified n.a. Ratio ED50 = 23.0 n.a. PMID[23398362]
NPT2 Others Unspecified n.a. Ratio ED50 = 19.0 n.a. PMID[20805391]
NPT2 Others Unspecified n.a. Ratio ED50 = 7.0 n.a. PMID[8450319]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC281581 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8861 High Similarity NPC475479
0.8395 Intermediate Similarity NPC323537
0.7701 Intermediate Similarity NPC11296
0.7701 Intermediate Similarity NPC274661
0.7317 Intermediate Similarity NPC73492
0.7317 Intermediate Similarity NPC299990
0.6941 Remote Similarity NPC475393
0.6932 Remote Similarity NPC243454
0.6737 Remote Similarity NPC175890
0.6632 Remote Similarity NPC191132
0.631 Remote Similarity NPC76682
0.631 Remote Similarity NPC10908
0.631 Remote Similarity NPC63646
0.631 Remote Similarity NPC317145
0.631 Remote Similarity NPC198498
0.631 Remote Similarity NPC115284
0.6235 Remote Similarity NPC276890
0.6211 Remote Similarity NPC82457
0.617 Remote Similarity NPC239584
0.6146 Remote Similarity NPC485711
0.6129 Remote Similarity NPC24260
0.573 Remote Similarity NPC12424
0.573 Remote Similarity NPC129518
0.573 Remote Similarity NPC251580
0.5682 Remote Similarity NPC41376
0.5673 Remote Similarity NPC256124
0.5667 Remote Similarity NPC603853
0.5644 Remote Similarity NPC48490
0.5625 Remote Similarity NPC317439
0.5618 Remote Similarity NPC227060
0.5604 Remote Similarity NPC480587
0.5545 Remote Similarity NPC475597
0.5484 Remote Similarity NPC311973
0.5435 Remote Similarity NPC290582
0.5435 Remote Similarity NPC217748
0.5435 Remote Similarity NPC182052
0.5435 Remote Similarity NPC271013
0.5435 Remote Similarity NPC42663
0.5435 Remote Similarity NPC15414
0.5426 Remote Similarity NPC116465
0.5422 Remote Similarity NPC247639
0.5422 Remote Similarity NPC25084
0.5376 Remote Similarity NPC279228
0.5263 Remote Similarity NPC185639
0.5263 Remote Similarity NPC251735
0.5263 Remote Similarity NPC49075
0.5263 Remote Similarity NPC599951
0.5158 Remote Similarity NPC239824
0.5152 Remote Similarity NPC485712
0.5104 Remote Similarity NPC254441
0.5104 Remote Similarity NPC223690
0.5104 Remote Similarity NPC9532
0.5056 Remote Similarity NPC475215
0.505 Remote Similarity NPC10871
0.5048 Remote Similarity NPC60295

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC281581 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.631 Remote Similarity NPD8099 Discontinued
0.6023 Remote Similarity NPD8156 Discontinued
0.5604 Remote Similarity NPD8095 Phase 1

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data